Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Moore

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Marine Pollution Bulletin|November 24, 2012
Physical dynamics controlling variability in nearshore fecal pollution: fecal indicator bacteria as passive particlesM A Rippy, P J S Franks, F Feddersen, et al.
Marine Pollution Bulletin|November 27, 2012
Factors controlling variability in nearshore fecal pollution: the effects of mortalityM A Rippy, P J S Franks, F Feddersen, et al.
Nanotechnology|September 10, 2009
Simultaneous magnetically directed drug convection and MR imagingV Yathindranath, T Hegmann, J van Lierop, et al.
Journal of Applied Microbiology|August 20, 2005
Evaluation of antibiotic resistance analysis and ribotyping for identification of faecal pollution sources in an urban watershedD F Moore, V J Harwood, D M Ferguson, et al.
Journal of Applied Microbiology|May 16, 2006
Comparison of 16S rRNA sequencing with conventional and commercial phenotypic techniques for identification of enterococci from the marine environmentD F Moore, M H Zhowandai, D M Ferguson, et al.
American Journal of Clinical Oncology|December 1, 1995
Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinomaD F Moore, R Pazdur, S Sugarman, et al.
Investigational New Drugs|January 19, 2000
Phase II trial of menogaril in non-Hodgkin's lymphomas: a Southwest Oncology Group trialD F Moore, T D Brown, M LeBlanc, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Recombinant interleukin-2 in combination with recombinant interferon-gamma in patients with advanced malignancy: a phase 1 studyS P Reddy, R M Harwood, D F Moore, et al.
Stroke|July 7, 2001
Enhanced endothelium-dependent vasodilation in Fabry diseaseG Altarescu, D F Moore, R Pursley, et al.
Prostate Cancer and Prostatic Diseases|April 27, 2011
Treatment profile and complications associated with cryotherapy for localized prostate cancer: a population-based studyC B Roberts, T L Jang, Yu-Hsuan Shao, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Marine Pollution Bulletin|November 24, 2012
Physical dynamics controlling variability in nearshore fecal pollution: fecal indicator bacteria as passive particlesM A Rippy, P J S Franks, F Feddersen, et al.
Marine Pollution Bulletin|November 27, 2012
Factors controlling variability in nearshore fecal pollution: the effects of mortalityM A Rippy, P J S Franks, F Feddersen, et al.
Nanotechnology|September 10, 2009
Simultaneous magnetically directed drug convection and MR imagingV Yathindranath, T Hegmann, J van Lierop, et al.
Journal of Applied Microbiology|August 20, 2005
Evaluation of antibiotic resistance analysis and ribotyping for identification of faecal pollution sources in an urban watershedD F Moore, V J Harwood, D M Ferguson, et al.
Journal of Applied Microbiology|May 16, 2006
Comparison of 16S rRNA sequencing with conventional and commercial phenotypic techniques for identification of enterococci from the marine environmentD F Moore, M H Zhowandai, D M Ferguson, et al.
American Journal of Clinical Oncology|December 1, 1995
Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinomaD F Moore, R Pazdur, S Sugarman, et al.
Investigational New Drugs|January 19, 2000
Phase II trial of menogaril in non-Hodgkin's lymphomas: a Southwest Oncology Group trialD F Moore, T D Brown, M LeBlanc, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Recombinant interleukin-2 in combination with recombinant interferon-gamma in patients with advanced malignancy: a phase 1 studyS P Reddy, R M Harwood, D F Moore, et al.
Stroke|July 7, 2001
Enhanced endothelium-dependent vasodilation in Fabry diseaseG Altarescu, D F Moore, R Pursley, et al.
Prostate Cancer and Prostatic Diseases|April 27, 2011
Treatment profile and complications associated with cryotherapy for localized prostate cancer: a population-based studyC B Roberts, T L Jang, Yu-Hsuan Shao, et al.
Pageof 11